The objective of this contract is to produce, scale-up, characterize and formulate reagent grade (GLP) and /or clinical grade (cGMP) HIV-1recombinant whole-killed vaccine products for animal and/or human trials. For clinical grade materials the manufacturer must perform all required vaccine lot characterization tests. The contractor must also work together with other contractors performing safety and immunogenicity testing of the vaccine product or producing FDA-required documentation in support of an IND.

Project Start
1999-07-09
Project End
2006-07-09
Budget Start
2000-08-01
Budget End
2000-11-30
Support Year
Fiscal Year
2000
Total Cost
$463,287
Indirect Cost
Name
Novartis Vaccines and Diagnostics, Inc.
Department
Type
DUNS #
332657949
City
Cambridge
State
MA
Country
United States
Zip Code
02139